Member Info for Computer909

I don't think we will see these made public any time soon and i think MHRA home use approval is purposely being withheld. We currently have an issue with the UK in that the restrictions are being ignored and pushed back on. This will only get worse if a section of the public claim to have antibodies and are "immune", we suddenly become a two tier society, this is the issue with any immunity passport being proposed. Like it or not large use of antibody testing across the general population is inherently linked to a vaccine. Looks like the government understand that and are ramping pre for production and storage.

IMO

With the Antibody test we sit in Pillar 3 of the test & trace system, which currently gets very little attention, however this will change with any vaccine release. with a vaccine realistically you need at least 2 tests, pre and post, then you could need one every six months, that will be transformational for the UK-RTC as we have a foot in the door with the government, why would they go elsewhere. If the Mologic antigen test gets sorted and we start picking up contracts from Pillar 1&2 then the cream on top,

We (VAST) keep paying the bills, AP Mining keep getting 20% of the benefit with out it costing them a bean, If AP continues to drive VAST into the ground he's the only one that benefits, The guy is corrupt but not stupid

You cant add the placing cash into the mcap valuation, that becomes working capital. Surely as with any dilution its basicallly 330M/(149+49)=1.66

Mhra approval early this week and Deeks looks even more of an idiot, i’m sure some civil servant is running around whitehall now looking to unblock the approval to head off any issues with the intended home use , i think he has done us a favour

https://pharmaphorum.com/news/uk-has-no-plans-to-buy-rapid-covid-19-test-favoured-by-us-and-who/

Hopefully that means they will back the UK-RTC/Mologic Antigen test when we are ready, if they had backed Abbott i think we would have struggled to dislodge an existing supplier

What we need to remember is that Pilar 3 (Antibody testing) is currently the poor relation in the track and trace family, Pillars 1&2 is where the money is being spent (Until a Vaccine is rolled widespread), I we can get the Antigen test to market before year end, thats the game changer.

The problem is AP is always looking for what he can blame the next placing on, likely to be based on the cost of the move to level 19 next, rather than consolidating the revenue flow and letting us see a rise in the SP.

http://bidstats.uk/tenders/2020/W41/736559165

@safy, the government have issued many multi million contracts (£161M to dnanudge fir example) i dont see your reasoning around a larger contract causing a storm

Could today’s drop be because the Uk-rtc contract is realistically the smallest they could have given us, less than two weeks worth of production capacity, we are left hanging on home use approval to really make a difference, the uk government contract is now just a means to the home use market

No doctor on a COVID ward is reaching for the MAP brochure, they are reaching for the stage treatment guidelines issued by the health board and NHS, until SNG001 is on that list we wont see usage outside of trials and validation exercise.

The MAP access will get us nowhere, No doctor is going to use a drug only available via MAP for the early stage treatment of any disease, it is simply too much effort and opens them up to liability if anything goes wrong, MAP access drugs for life or death decision points i can see, but not early stage treatment.

What is missing is the peer review of the results, without that it wont be taken serious by any Government or Approval agency.

We have no update on when the peer review will be complete, we have no update on an EUA, We have no update on any partnership that will get SNG001 to market, all we have is a MAP agreement that will see single figure doses being issued, Mean while patient numbers rise and the number of death keeps going up. If 79% improvement is a reality surely we would see some progress by now,

To get an idea of peer review duration : https://scirev.org/reviews

Until we at least see an output from the peer review there is no way the Government are going to even look at EUA, The lack of peer review is the elephant in the room that has to be addressed if we to get away from the natural SP slide on no news

we know what the Share Price is?, ALL-EQUITY TAKEOVER,

The presentation was like a car crash edition of Dragon's Den, an Engineer trying to be a businessman, the product would take millions if not billions to deploy, Government approval across the globe for the digital health passport use, a reader on every street like and ATM, do they know the cost of maintaining the ATM infrastructure across the globe, land rent, power, internet connection. and who on earth thinks that in a global pandemic of a respiratory disease asking someone to take a deep breath of god knows what, out of an inhaler every day was going to be attractive to anyone, let alone trotting off to the local reader just visited by the super spreader. This on top of not being ready for six months when 5 min Lateral flow antigen tests will be be available from multiple sources by the end of the year. Time to forget the inhaler and get back to the fundamentals the company thrived on, the Water Testing, and put the inhaler behind us.

If they do, AP will print some more next month